Clinical trials
Phase 1 Renal Insufficiency, Chronic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 6 |
| Unknown status | 4 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shandong Suncadia Medicine Co., Ltd. | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Amgen | 1 |
| Bayer | 1 |
| Beijing Continent Pharmaceutical Co, Ltd. | 1 |
| Consun Pharmaceutical Group | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Liu Zhanghong | 1 |
| Novo Nordisk A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency, Chronic | 20 |
| Calciphylaxis | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hyperparathyroidism, Secondary | 1 |
| Rare Diseases | 1 |
| Renal Artery Obstruction | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.